Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System | Coagulation Disorders | JAMA

This study examines the incidence of and risk factors for venous and arterial thrombosis in patients hospitalized with COVID-19 in 4 New York City hospitals.

Related Keywords

New York ,United States ,New York University ,Siddhant Dogra ,Jodyw Zylke ,Jeffreys Berger ,Gemma Simon ,Ji Chen ,Meng Cao ,Ruina Zhang ,Grossman School Of Medicine Institutional Review Board ,Arbor Pharmaceuticals ,National Center ,Amgen Inc ,National Heart ,York University School Of Medicine ,Medtronic Inc ,York University ,Astrazeneca Pharmaceuticals ,Langone Health ,Omron Healthcare Inc ,Translational Sciences ,Merck Sharp Dohme Corp ,Grossman School Of Medicine ,Volcano Corp ,Blood Institute ,Astrazeneca ,St Jude Medical Inc ,Amgen ,Medicine Institutional Review Board ,New York City ,Cardiovascular Disease ,New York University School ,Interest Disclosures ,Abbott Vascular ,Merck Sharp ,Dohme Corp ,Advancing Translational ,